Estimation of drug-target residence times by τ-random acceleration molecular dynamics simulations

…, U Grädler, D Musil, HP Buchstaller… - Journal of chemical …, 2018 - ACS Publications
Drug-target residence time (τ), one of the main determinants of drug efficacy, remains highly
challenging to predict computationally and, therefore, is usually not considered in the early …

Large-scale assessment of binding free energy calculations in active drug discovery projects

…, A Blum, D Böse, HP Buchstaller… - Journal of Chemical …, 2020 - ACS Publications
Accurate ranking of compounds with regards to their binding affinity to a protein using
computational methods is of great interest to pharmaceutical research. Physics-based free energy …

The discovery and optimization of hexahydro-2H-pyrano [3, 2-c] quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5

…, C Amendt, T Knöchel, D Bruge, HP Buchstaller… - Bioorganic & medicinal …, 2010 - Elsevier
Here we describe the discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs)
as potent and selective inhibitors of the mitotic kinesin-5 originally found during a …

[HTML][HTML] A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors

…, ER Johnson, C Esdar, HP Buchstaller… - Scientific Reports, 2019 - nature.com
Inhibition of the PARP superfamily tankyrase enzymes suppresses Wnt/β-catenin signalling
in tumour cells. Here, we describe here a novel, drug-like small molecule inhibitor of …

Ligand desolvation steers on-rate and impacts drug residence time of heat shock protein 90 (Hsp90) inhibitors

…, U Grädler, D Musil, HP Buchstaller… - Journal of Medicinal …, 2018 - ACS Publications
Residence time and more recently the association rate constant k on are increasingly
acknowledged as important parameters for in vivo efficacy and safety of drugs. However, their …

Discovery and optimization of 2-arylquinazolin-4-ones into a potent and selective tankyrase inhibitor modulating Wnt pathway activity

HP Buchstaller, U Anlauf, D Dorsch… - Journal of Medicinal …, 2019 - ACS Publications
Tankyrases 1 and 2 (TNKS1/2) are promising pharmacological targets that recently gained
interest for anticancer therapy in Wnt pathway dependent tumors. 2-Aryl-quinazolinones were …

Identification of M4205─ A highly selective inhibitor of KIT mutations for treatment of unresectable metastatic or recurrent gastrointestinal stromal tumors

…, N Linde, S Brandstetter, HP Buchstaller… - Journal of Medicinal …, 2023 - ACS Publications
The treatment of gastrointestinal stromal tumors (GISTs) driven by activating mutations in the
KIT gene is a prime example of targeted therapy for treatment of cancer. The approval of the …

Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor

HP Buchstaller, CD Siebert, R Steinmetz… - Journal of medicinal …, 2006 - ACS Publications
The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one
(21), was used as a template for bioisostere benzene/…

Solid phase synthesis of oxazolidinones via a novel cyclisation/cleavage reaction

HP Buchstaller - Tetrahedron, 1998 - Elsevier
The solid phase synthesis of oxazolidinones via a novel cylisation/cleavage reaction is
described. Resin bound carbamates 2, which were obtained by reaction of Wang-resin with …

[HTML][HTML] 3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors

…, R Hargest, AR Clarke, C Esdar, HP Buchstaller… - PLoS …, 2020 - journals.plos.org
Aberrant activation of the Wnt signalling pathway is required for tumour initiation and survival
in the majority of colorectal cancers. The development of inhibitors of Wnt signalling has …